To understand contributing factors that may be supporting NANOG activation and cancer stemness, we also checked β‐catenin (Valkenburg et al, 2011) and HIF‐1α as a known activator of P4HA2 (Gilkes et al, 2013). The gene discussed is P4HA2; the disease is cancer.